Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA243072,10.3324/haematol.2023.283225,Haematologica,37439336,https://pubmed.ncbi.nlm.nih.gov/37439336,Down syndrome and leukemia: from basic mechanisms to clinical advances,2023,,"Andre Baruchel, Jean-Pierre Bourquin, John Crispino, Sergi Cuartero, Henrik Hasle, Johann Hitzler, Jan-Henning Klusmann, Shai Izraeli, Andrew A Lane, Sebastien Malinge, Karen R Rabin, Irene Roberts, Sandra Ryeom, Sarah K Tasian, Elvin Wagenblast","Children with Down syndrome (DS, trisomy 21) are at a significantly higher risk of developing acute leukemia compared to the overall population. Many studies investigating the link between trisomy 21 and leukemia initiation and progression have been conducted over the last two decades. Despite improved treatment regimens and significant progress in iden - tifying genes on chromosome 21 and the mec(Read more on Pubmed)",Modeling,"B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, Myeloid Leukemia",Blood,Not Appicable,Open Access,37439336,1682a1f8-00a3-4bcd-97a0-7c9f7f2db8db,syn52565490
